Hyperuricemia in hospitalized patients with heart failure: prevalence and clinical correlates - Summary - MDSpire

Hyperuricemia in hospitalized patients with heart failure: prevalence and clinical correlates

  • By

  • Lingqin Li

  • Xinzhu Yuan

  • Yanni Zhang

  • Quanbo Zhang

  • Yufeng Qing

  • July 15, 2026

Share

Objective:

To evaluate the burden of hyperuricemia in hospitalized patients with heart failure (HF) and explore its associated clinical correlates.

Approach:
  • Study Design: Retrospective cross-sectional analysis of 1,985 patients admitted with HF.
  • Hyperuricemia Definition: Defined as serum uric acid ≥ 7.0 mg/dL in males and ≥ 6.0 mg/dL in females.
  • Statistical Analysis: Used univariable and multivariable logistic regression models, restricted cubic spline analyses, and subgroup analyses.
Key Findings:
  • Overall prevalence of hyperuricemia was 69.42%.
  • Prevalence was consistent across sex, age, and BMI groups but varied by NYHA class.
  • In the multivariable model, hyperuricemia was independently associated with renal dysfunction, hemodynamic impairment, electrolyte imbalance, and metabolic disturbance.
Interpretation:

Hyperuricemia in hospitalized HF patients may reflect a broader cardiorenal and metabolic profile.

Limitations:
  • Study based on a single-center dataset.
  • Retrospective design may limit causality conclusions.
Conclusion:

Hyperuricemia is highly prevalent among hospitalized HF patients and is associated with multiple clinical markers.

Original Source(s)

Related Content